Země: Singapur
Jazyk: angličtina
Zdroj: HSA (Health Sciences Authority)
BROMOCRIPTINE MESYLATE EQV BROMOCRIPTINE
NOVARTIS (SINGAPORE) PTE LTD
G02CB01
2.5 mg
TABLET
ORAL
Prescription Only
NOVARTIS FARMA S P A
1988-05-12
PARLODEL Dopamine agonist, prolactin inhibitor DESCRIPTION AND COMPOSITION PHARMACEUTICAL FORMS Bromocriptine mesylate One scored tablet contains bromocriptine mesylate 2.87 mg (corresponding to 2.5 mg bromocriptine base). One capsule contains bromocriptine mesylate 5.74 mg or 11.47 mg (corresponding to 5.0 mg or 10.0 mg bromocriptine base). One capsule SRO contains bromocriptine mesylate 2.87 mg, 5.74 mg or 11.47 mg (corresponding to 2.5 mg, 5.0 mg or 10.0 mg bromocriptine base). Certain dosage forms and dosage strengths may not be available in all countries. ACTIVE MOIETY Bromocriptine INDICATIONS PARKINSON’S DISEASE All stages of idiopathic and postencephalitic Parkinson’s disease, either as monotherapy or in combination with other antiparkinsonian drugs. PROLACTINOMAS Conservative treatment of prolactin-secreting pituitary micro- or macro-adenomas. Prior to surgery in order to reduce tumour size and to facilitate removal. After surgery if prolactin level is still elevated. ACROMEGALY As an adjunct, or in special cases as an alternative, to surgery or radiotherapy. HYPERPROLACTINAEMIA IN MEN Prolactin-related hypogonadism (oligospermia, loss of libido, impotence). MENSTRUAL CYCLE DISORDERS, FEMALE INFERTILITY Prolactin-dependent hyperprolactinaemic or apparently normoprolactinaemic conditions Novartis Page 2 Country Specific Package Leaflet (Singapore) Jan 2013 Parlodel amenorrhoea (with or without galactorrhoea), oligomenorrhoea, luteal phase deficiency, drug-induced hyperprolactinaemic disorders (e.g. induced by certain psychotropic or antihypertensive agents). Prolactin-independent female infertility polycystic ovary syndrome, anovulatory cycles (supplementary to anti-estrogens, e.g. clomiphene). Parlodel Přečtěte si celý dokument